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A.Mohamadani3 and Osman Khalfalla Saeed1 
Abstract  
Background: Nonspecific colitis is an inflammatory Bowel Disease (IBD) that runs a clinically 
benign course. Histopathologically it is characterized by superficial mucosal erosions with 
lymphocytic infiltration in the lamina propria with no granuloma. 
Aim of this study: is to describe the clinical presentation of Non-Specific Colitis (NSC), and to 
evaluate its response to 5-aminosalicylic acid (5-ASA) in Sudanese patients.  
Setting and Design: This study is a prospective cohort. A total of 26 patients presenting with 
bloody, mucoid diarrhoea, lower abdominal pain or colonic mass were included in the study.   
Methods and Materials: A total of 26 patients presenting with bloody mucoid diarrhoea, lower 
abdominal pain with or without colonic mass were included in the study. All patients underwent 
colonoscopy.  Statistical analysis: A descriptive statistical analysis was done using SPSS.   
Results: 19 (%) of patients were males and 7 were females with male to female ratio of 3:1. The 
majority of patients 16 (61.6%) had bloody diarrhea while 18 (69.2%) opened their bowel 4-6 times 
a day. The majority 10 (38.8%) had rectum and sigmoid involvement. All patients showed a good 
response to 5-ASA.     
Conclusions: This study showed that NSC has clinical features that are very much similar to mild 
UC with a rather good clinical response to oral 5-ASA.  
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he term indeterminate colitis (IC) is an 
interim, or preliminary descriptive 
term used by pathologists for cases of 
inflammatory bowel disease (IBD) in which a 
definite diagnosis of ulcerative colitis (UC) or 
Crohn's disease (CD) cannot be established. 
Most cases are due to fulminant ulcerative 
colitis, a condition in which the classic 
pathologic features of UC are often obscured 
and may overlap with CD1. The measurement 
of perinuclearantineutrophic cytoplasmic 
antibodies (P-ANCA) and anti- 
saccharomyces cervisiae (ASCA) antibodies 
has been suggested as a method to 
differentiate UC form CD 2,3.The sensitivity 
of these tests is only 40-60%, limiting their 
usefulness in IC3.  
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The aim of this study is to describe the 
clinical presentation of NSC, and to evaluate 
its response to 5-aminosalicylic acid (5-ASA) 
in Sudanese patients. 
 
Methods 
Thestudy was conducted in Gezira Centre for 
Gastrointestinal Endoscopy and Laparoscopic 
Surgery in Gezira State Central Sudan, in the 
period from 2006 to 2007. A total of 33 
patients presenting with bloody mucoid 
diarrhoea, lower abdominal pain with or 
without colonic mass were included in the 
study.  After explaining the purpose of the 
study, a written informed consent was 
obtained. A protocol including a detailed 
history, physical examination, full blood 
count, ultrasonography and stool examination 
was performed. All patients underwent 
colonoscopy using videocolonscope Olympus 
EVIS EXERA, CV-145 type. The biopsies 
were examined for histopathology. Colonic 
biopsies showing features of nonspecific 









































































alal et al.    








 of 6 wee

































e 6 months -
 showed th













rsion 10.  
 patients. 1
 were 7 (26
ith age rang


























10 years.  
at the rectum
                N
                
C on IC 
fined as 
mphocytic 
ia with no 
salaziane, 
s per day 














ts.   
nts 18/26 
mes a day 
bowel at 






as 22.5 ± 





















































 in the study







m rect. and A




















































































































s in  
Moawia Elbalal et al.                                       Nonspecific colitis a forgotten entity in Central Sudan 
 
© Sudan JMS Vol. 5, No.4. Dec 2010                  297 
 
stool. No patients developed hypersensitivity 
or other obvious toxicity from 5-ASA in this 
study.   
 
Discussion 
There are no randomized clinical trials of 
medical therapy for IC. Assumptions have 
been made that patients with IC have a 
clinical course similar to UC and therefore 
medical therapy follows the approach one 
would use for UC. Therapy include 5-ASA 
suppositories and or topical steroids for 
proctitis and proctosigmoiditis4. 
In 1978, Price introduced the term IC to refer 
to a subgroup of approximately 10-15% of 
IBS cases in which there was difficulty in 
distinguishing between UC and CD because 
the features of the typical severe UC were 
replaced by deep ulcer, relative rectal sparing 
and trasmural inflammation5. Typical CD 
fissuring type ulcerations were seen in 13% of 
cases of IC but the other histological feature 
of these IC cases reported so atypical that a 
diagnosis of CD could not be justified. The 
presence of scattered mononuclear 
inflammatory cells in the muscularis propria 
adjacent to ulceration was regarded as a non-
specific response and is not a discriminating 
feature between UC and CD. This nonspecific 
response could be due to a disease in mucosa 
caused by an organism that was not identified 
on routine stool culture6. 
The evaluation of IC is done by histological 
examination of colonic specimens. This was 
shown to carry inter-observer variation7. 
Another modality of evaluations is the use of 
upper GIT endoscopy to link gastro-
duodenitis caused by Helicobactorplori to 
both UC and CD especially in children 8-13. 
There is no clear definition of nonspecific 
colitis (NSC) in the literature. It is a term that 
is similar to indeterminate colitis (IC), in that 
it is between ulcerative colitis (UC) and CD1.  
The study showed that males are 
outnumbering the males (19 versus 7) and 
their age is clustering around 31 to 40 years 
(38.5%). Sixteen (61.6%) of the study group 
presented with bloody mucoid diarrhoea or a 
lower abdominal pain and (30.8.6%) 6/26 
open their bowel at the night. These features 
are consistent with UC presentation15. 
During colonoscopy the rectum and sigmoid 
colon were found to be invariably in involved 
and in (38.5%) have tinny superficial ulcers 
that turned to have features of NSC in a 
pattern similar to colonic involvement in 
UC16, 15. 
5-ASA is usually used to maintain the 
remission after controlling the acute attack of 
UC colitis 17.In this study it was used as oral 
medication to treat cases of NSC. All patients 
showed a good response. 
In conclusion NSC showed clinical features 
that are very much similar to mild UC with a 
fairly good clinical response to oral 5-ASA. A 
search for causative organisms should be 
made and a course of an oral corticosteriods 
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